National Research Centre

Medical Research Ethics Committee

MREC Reviewer Comment

Protocol Title

Fabrication of Carboxymethyl Cellulose/PVA-Sulfonamide Composite for the Amelioration of Benign Prostatic Hyperplasia in Rats via Modulating NRF2/NF-κB, PI3K/AKT, and NOX-2/NLRP3 Pathways

Completely satisfied and informative data

Needs Explanation

Comments to the applicant

1-The title includes abbreviations (NRF2/NF-κB, PI3K/AKT, and NOX-2/NLRP3) that need to be explained in detail.

2-The experiment is scheduled to last 7 months in the Gantt chart, but it states 2 months.

3-The methodology written should be revised to be presented in the present tense.

4-The authors stated that the project had not been revised, despite having signatures from the head of the department and the dean of the institute on Form 90.

5-They wrote that the fund will be self, and in another application is 20000 LE, they must add it to the application

6- The prostate cancer cells (PC3 cells) were obtained from the American Type Culture Collection (ATCC). Was this material purchased, or is it available through collaboration?

7- What is the Azodye used in PC3 cells tissue culture at different doses, including the company and its role in cancer treatment?

8-The abbreviations SO and SD are not commonly known; they should be clearly defined to understand their role in treating prostate enlargement.

9- The experiments are 7 groups, while they wrote that the number of animal are 10/group, then 8/groups it must be clear.

Comment to the Committee

The authors stated that the project had not been revised, despite having signatures from the head of the department and the dean of the institute on Form 90.

Informed consent form:

Waiver

Login

Email Address *
Enter your username or email address
password *
Enter your password

Reset Password

Enter Your Email
Please insert your email and check your email for rest password link

Still not a member? Register